Dr. Fotios Koumpouras, MD

Dr. Koumpouras practices at Yale Medicine in New Haven, Connecticut.

Dr. Koumpouras' NPI, 1316982218, was assigned on June 17, 2006. Dr. Koumpouras graduated from St. George's University School of Medicine in 2000. Dr. Koumpouras' Connecticut license number on file is 042299.

Dr. Koumpouras' primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Koumpouras' primary practice is Yale Medicine in New Haven, Connecticut. Dr. Koumpouras is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Koumpouras to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koumpouras practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Koumpouras' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Koumpouras is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Koumpouras' licenses on file in 3 states: Connecticut, Pennsylvania and New York.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, joint arthropathy, lupus, muscle disease, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Koumpouras treats.

CMS data shows 158 Medicare services from Dr. Koumpouras across 3 procedure codes in 2024, for 91 Medicare patients. Medicare paid $12,718 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Dr. Koumpouras in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have arthritis, and 69% have high blood pressure. 46% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koumpouras' median patient age at 59, with 79% women.

In 2024, Dr. Koumpouras wrote 1,317 Medicare Part D claims for 152 patients. 79% of them were for generic drugs. CMS names the drug for 1,051 of them, across 33 drugs with 11 or more claims each, at $643,584 in total drug cost. In 2023, CMS named 1,018 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Koumpouras for performance year 2024, reported as part of a group. Dr. Koumpouras accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koumpouras as offering telehealth.

Dmand AI links 21 papers to Dr. Koumpouras, published from 2014 to 2025. 2025 was the busiest year, with 8. The most frequent topics are Lupus Erythematosus, Systemic, Autoantibodies and Disease Models, Animal. Dr. Koumpouras has published most often in Arthritis Rheumatol. Dr. Koumpouras' most frequent co-authors are Jeff R. Gehlhausen, MD, PhD, Anca D. Askanase, MD and Ratnesh Chopra, MD.

Dmand AI links Dr. Koumpouras to 11 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Lupus Erythematosus, Systemic, Connective Tissue Diseases and Dermatomyositis. Ampel BioSolutions, LLC sponsors the most, 2. Open Payments lists research payments to Dr. Koumpouras that name 1 trial.

CMS Open Payments shows 427 general payments to Dr. Koumpouras from 10 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. AstraZeneca Pharmaceuticals LP paid the most, $173,401. It also lists 1 research payment totaling $41 in 2020, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Koumpouras, most recently CMS Stage 1 EHR in 2013.

Dr. Koumpouras graduated from St. George's University School of Medicine in 2000. Dr. Koumpouras is a member of ACR.

Dr. Koumpouras is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.